These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 32362486)
1. Lactobacillus reuteri DSM 17938 is effective in the treatment of functional abdominal pain in children: Results of the double-blind randomized study. Jadrešin O; Sila S; Trivić I; Mišak Z; Kolaček S; Hojsak I Clin Nutr; 2020 Dec; 39(12):3645-3651. PubMed ID: 32362486 [TBL] [Abstract][Full Text] [Related]
2. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study. Jadrešin O; Hojsak I; Mišak Z; Kekez AJ; Trbojević T; Ivković L; Kolaček S J Pediatr Gastroenterol Nutr; 2017 Jun; 64(6):925-929. PubMed ID: 27906800 [TBL] [Abstract][Full Text] [Related]
3. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. Weizman Z; Abu-Abed J; Binsztok M J Pediatr; 2016 Jul; 174():160-164.e1. PubMed ID: 27156182 [TBL] [Abstract][Full Text] [Related]
4. Lactobacillus reuteri in children with functional abdominal pain (FAP). Romano C; Ferrau' V; Cavataio F; Iacono G; Spina M; Lionetti E; Comisi F; Famiani A; Comito D J Paediatr Child Health; 2014 Oct; 50(10):E68-71. PubMed ID: 20626584 [TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri DSM 17938 and a placebo both significantly reduced symptoms in children with functional abdominal pain. Maragkoudaki M; Chouliaras G; Orel R; Horvath A; Szajewska H; Papadopoulou A Acta Paediatr; 2017 Nov; 106(11):1857-1862. PubMed ID: 28712129 [TBL] [Abstract][Full Text] [Related]
6. Use of probiotics in the treatment of functional abdominal pain in children-systematic review and meta-analysis. Trivić I; Niseteo T; Jadrešin O; Hojsak I Eur J Pediatr; 2021 Feb; 180(2):339-351. PubMed ID: 32940743 [TBL] [Abstract][Full Text] [Related]
7. The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial. Wegner A; Banaszkiewicz A; Kierkus J; Landowski P; Korlatowicz-Bilar A; Wiecek S; Kwiecien J; Gawronska A; Dembinski L; Czaja-Bulsa G; Socha P Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):494-500. PubMed ID: 29650440 [TBL] [Abstract][Full Text] [Related]
8. Lack of Benefit of Lactobacillus reuteri DSM 17938 as an Addition to the Treatment of Functional Constipation. Jadrešin O; Sila S; Trivić I; Mišak Z; Hojsak I; Kolaček S J Pediatr Gastroenterol Nutr; 2018 Dec; 67(6):763-766. PubMed ID: 30134331 [TBL] [Abstract][Full Text] [Related]
9. Probiotics in Functional Gastrointestinal Disorders. Hojsak I Adv Exp Med Biol; 2019; 1125():121-137. PubMed ID: 30578460 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of the prenatal administration of Lactobacillus reuteri LR92 DSM 26866 on the prevention of infantile colic: a randomized control trial. Pourmirzaiee MA; Famouri F; Moazeni W; Hassanzadeh A; Hajihashemi M Eur J Pediatr; 2020 Oct; 179(10):1619-1626. PubMed ID: 32372186 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Urbańska M; Szajewska H Eur J Pediatr; 2014 Oct; 173(10):1327-37. PubMed ID: 24819885 [TBL] [Abstract][Full Text] [Related]
12. Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial. Kubota M; Ito K; Tomimoto K; Kanazaki M; Tsukiyama K; Kubota A; Kuroki H; Fujita M; Vandenplas Y Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952280 [TBL] [Abstract][Full Text] [Related]
13. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. Dinleyici EC; Dalgic N; Guven S; Metin O; Yasa O; Kurugol Z; Turel O; Tanir G; Yazar AS; Arica V; Sancar M; Karbuz A; Eren M; Ozen M; Kara A; Vandenplas Y J Pediatr (Rio J); 2015; 91(4):392-6. PubMed ID: 25986615 [TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study. Francavilla R; Lionetti E; Castellaneta S; Ciruzzi F; Indrio F; Masciale A; Fontana C; La Rosa MM; Cavallo L; Francavilla A Aliment Pharmacol Ther; 2012 Aug; 36(4):363-9. PubMed ID: 22680836 [TBL] [Abstract][Full Text] [Related]
15. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Dinleyici EC; ; Vandenplas Y Acta Paediatr; 2014 Jul; 103(7):e300-5. PubMed ID: 24579935 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial. Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445 [TBL] [Abstract][Full Text] [Related]
20. Nutraceuticals and Pain Disorders of the Gut-Brain Interaction in Infants and Children: A Narrative Review and Practical Insights. Salvatore S; Carlino M; Sestito S; Concolino D; Agosti M; Pensabene L Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]